Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM
Clinical trial NCT07150104 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07150104
- Sponsor
- GlaxoSmithKline
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-31
- Primary completion
- 2025-04-17
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.